Lopinavir and Ritonavir
NDC 33342-164, Lopinavir and Ritonavir, tablet, film coated, from Macleods Pharmaceuticals Limited.
- Product NDC
- 33342-164
- Status
- Listed
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204739
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/33342-164 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LOPINAVIR200 mg/1
- RITONAVIR50 mg/1
Pharmacologic classes
Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A Inhibitor [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; HIV Protease Inhibitors [MoA]; Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Protease Inhibitor [EPC]; Protease Inhibitor [EPC]; UDP Glucuronosyltransferases Inducers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 33342-164-09 | 33342016409 | 60 TABLET, FILM COATED in 1 BOTTLE (33342-164-09) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/115178c8-5ee2-4d96-820e-ea8264c1ac10
Use it
Look up 33342-164 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/33342-164 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 33342-164. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.